Weight Loss Vault
Retatrutide
Next-generation triple pathway.
Retatrutide targets three metabolic receptors — GLP-1, GIP, and glucagon — for appetite suppression paired with increased energy expenditure.
- Newest compound in the vault
- Requires close follow-up with your provider
- Availability depends on your evaluation
Prescription only. A licensed provider determines whether Retatrutide is appropriate for you.
How it's taken
Weekly subcutaneous injection
Oversight
Licensed provider, ongoing follow-up
Delivery
Discreet shipping to your door
How it works
The science, in plain language.
Adding glucagon receptor activity to the incretin effect encourages fat mobilization alongside reduced intake. Because it is potent, dosing is conservative and closely supervised.
Benefits
What you can expect.
- Triple-receptor metabolic action
- Appetite control plus energy expenditure
- Option for patients seeking maximal support
- Physician-monitored titration
Questions
Good to know.
How soon will I see results?
Most patients notice reduced appetite within the first few weeks. Meaningful weight change typically appears over 8–12 weeks as your dose is titrated by your provider.
Do I need to inject it myself?
Yes — it is a small subcutaneous injection you give yourself weekly. Your care team walks you through it and you can message them any time.
Is this covered by insurance?
RISE Health Rx is a cash-pay telehealth practice. Pricing is transparent and shared with you after your consultation.
Safety
Important information.
Side effect profile is similar to other incretin therapies, with digestive symptoms most common. A full clinical review is required before starting.
This page is for general education and is not medical advice. Your treatment plan is determined by a licensed healthcare provider after evaluation.
Also in this vault
